Ketogenic Diet Therapy in Drug-Resistant Epilepsy – Clinical Benefits and Outcomes

This infographic provides healthcare professionals with a visual overview of the role of Ketogenic Diet Therapy (KDT) in managing drug-resistant epilepsy (DRE) in infants and children. Up to 30% of patients do not respond to anti-seizure medications (ASMs), and alternatives such as brain surgery or vagus nerve stimulation may not always be suitable. International guidelines now recommend KDT after failure of 2–3 drugs, with evidence showing significant improvements in seizure control, cognition, and quality of life.

The Takeaway for Healthcare Professionals

This resource helps you understand how KDT supports better outcomes. By exploring this infographic, you will:

• Review data showing up to 28% of children achieve seizure freedom and up to 60% experience >50% seizure reduction

• Learn how KDT improves sleep quality, cognition, and behavior in children with DRE

• Recognize the role of KDT in preventing long-term cognitive decline and supporting optimal psychomotor development

• Understand the benefits of KDT for both patients and families, including improved daily functioning and reduced treatment burden

• Gain awareness of guideline recommendations for initiating KDT after failure of standard therapies

View the Infographic on DNC

Take a moment to explore the full infographic directly on this page. It offers clear visuals, clinical evidence, and practical guidance to support your expertise in managing pediatric drug-resistant epilepsy with dietary therapies.